400 Farmington Avenue, MC 6409
Farmington, CT 06032
Carolyn Dealy, PhD, Scientific Advisor – email@example.com
Chondrogenics Inc. is developing stem cell therapy for the treatment of osteoarthritis and the repair of damaged cartilage associated with diseased and damaged joints. Dr. Caroline Dealy, Associate Professor in the Center for Regenerative Medicine and Skeletal Development at the University of Connecticut Health Center, and colleagues have developed a novel process for producing substantially homogeneous populations of chondrogenic cells and earlier progenitor cells from stem cells, including induced pluripotent stem cells. Dr. Dealy is leading studies to evaluate the efficacy of cartilage repair by these cells in animals. A $75,000 prototype grant from the University of Connecticut’s Center for Science and Technology Commercialization has been used to develop the necessary animal models and to conduct initial assessment of cartilage repair. A $1.3 million grant from the State of Connecticut Stem Cell Program will be used for comprehensive preclinical characterization of this new therapy in preparation for eventual human clinical trials.